Grade C aGVHD Completed Phase 3 Trials for Remestemcel-L (DB13973)

IndicationStatusPhase
DBCOND0127257 (Grade C aGVHD)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02336230A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)Treatment